Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · IEX Real-Time Price · USD
3.050
+0.170 (5.90%)
At close: Apr 29, 2024, 4:00 PM
2.990
-0.060 (-1.97%)
After-hours: Apr 29, 2024, 4:38 PM EDT
Century Therapeutics Revenue
In the year 2023, Century Therapeutics had annual revenue of $2.24M, a decrease of -57.01%. Revenue in the quarter ending December 31, 2023 was $268.00K, a -48.56% decrease year-over-year.
Revenue (ttm)
$2.24M
Revenue Growth
-57.01%
P/S Ratio
88.60
Revenue / Employee
$14,704
Employees
152
Market Cap
198.02M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.24M | -2.96M | -57.01% |
Dec 31, 2022 | 5.20M | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIPSC News
- 6 days ago - Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - GlobeNewsWire
- 18 days ago - Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics - GlobeNewsWire
- 21 days ago - Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 5 weeks ago - Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference - GlobeNewsWire
- 6 weeks ago - Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 weeks ago - Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 3 months ago - Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - GlobeNewsWire
- 5 months ago - Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits - GlobeNewsWire